The presence of type 2 diabetes is considered a risk factor for the development of chronic kidney disease (CKD). Simple screening measures based on blood and urine samples can detect CKD at an early stage. This is becoming increasingly important, as the progression of kidney failure – especially in the early stages – can now be effectively delayed with medication.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- Nephrologie-Special
Related Topics
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- Participation of the patient
Adherence in psychiatry
- From symptom to diagnosis
Renal cell carcinoma
- Lipid management: ESC/EAS guideline update 2025
New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH
- Chronically active MS lesions
New paradigm in the diagnosis and treatment of multiple sclerosis
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Participation of the patient
Adherence in psychiatry
- Eosinophilic esophagitis